OBS INNOVATION

Entomopathogenic fungal strain for biological control of aphids in sustainable agriculture

Technology
Conceptual
Company

An isolated fungal strain with strong entomopathogenic potential against multiple aphid species, offering a biological alternative to conventional insecticides. This biocontrol solution supports sustainable and ecological agriculture by reducing reliance on chemical treatments.

Overview

This solution presents an entomopathogenic fungal strain isolated for its strong ability to infect and control several species of aphids. Developed in response to the need for alternative solutions to conventional insecticide treatments, the strain aligns with the growing demand for sustainable and ecological agricultural practices. By leveraging a naturally occurring biological agent, this technology offers an environmentally friendly approach to managing aphid populations, which are among the most damaging pests in crop production worldwide.

The core value proposition lies in providing farmers and agricultural operators with an effective biocontrol tool that reduces dependence on chemical pesticides, supports integrated pest management strategies, and contributes to more sustainable food production systems.

Technical specifications
  • Isolated fungal strain with demonstrated entomopathogenic potential against multiple aphid species
  • Broad-spectrum efficacy observed across several aphid species, increasing its practical utility across diverse cropping systems
  • Biological control mechanism based on natural fungal pathogenicity toward aphids, offering an alternative to synthetic insecticide treatments
  • Sustainable agriculture alignment designed to support ecological farming practices and reduce chemical inputs
  • Internal validation conducted to confirm entomopathogenic activity against target aphid species
Technology readiness level

The fungal strain has been successfully isolated and initial validation has confirmed its strong entomopathogenic potential against several aphid species. Further development steps would include broader field validation, formulation optimization, mass production feasibility studies, and regulatory assessment for commercial deployment as a biocontrol product.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.